Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Art & Psychiatry
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Conference Oration
Conference Summary
Continuing Medical Education
Cosmetic Dermatology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
Editor Speaks
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Miscellaneous Letter
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News & Views
Observation Letter
Observation Letters
Original Article
Original Contributions
Pattern of Skin Diseases
Pediatric Dermatology
Pediatric Rounds
Presedential Address
Presidential Address
Presidents Remarks
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Study Letter
Study Letters
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapy Letter
Therapy Letters
View Point
What’s new in Dermatology
View/Download PDF

Translate this page into:

Therapy Letter
88 (
); 230-231

Residual limb hyperhidrosis successfully managed with topical glycopyrrolate

Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece
Corresponding author: Dr. Aikaterini Tsiogka, MD, MSc Hospital for Skin Diseases “A. Sygros”, 5 I. Dragoumi St. GR–16121 Athens, Greece.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Kotitsas P, Tsiogka A, Agiasofitou E, Markantoni V, Gregoriou S, Platsidaki E, et al. Residual limb hyperhidrosis successfully managed with topical glycopyrrolate. Indian J Dermatol Venereol Leprol 2022;88:230-1.


Residual limb hyperhidrosis is reported by up to 66% of patients with amputations and is associated with secondary dermatological complaints, such as acroangiodermatitis, contact dermatitis, infections and ulcerations. Moreover, it may result in reduced prosthetic fit and function, significantly impairing mobility and, therefore, quality of life.1

A 46-year-old female patient with a post-traumatic right transfemoral amputation presented for consultation due to focal stump hyperhidrosis. The patient wore an artificial leg for more than 20 years and suffered from progressive stump sweating, limiting the use of the prosthetic device. She did not have any comorbidities and did not receive any medications or previous treatment for stump hyperhidrosis. The hyperhidrosis disease severity scale score was four. A modified iodine-starch test, utilising a plastic wrap after applying the corn starch to assess the severity of hyperhidrosis under occlusion, revealed relevant sweating at the distal end of the residual limp [Figures 1a and 1b]. We decided to commence a galenic formulation of 2% glycopyrronium bromide in Fitalite (Fagron) applied twice daily on dry skin. Two weeks later, the patient reported a >75% improvement of hyperhidrosis and a hyperhidrosis disease severity scale score of two which could be also validated through the observed improvement in the result of iodine-starch test [Figure 1c]. Overall, the patient reported no side effects, including urinary retention or blurred vision, and her quality of life improved significantly, as reflected by a score reduction of the dermatology life quality index from 15 to two, before and after therapy with glycopyrrolate, respectively. Continuation of treatment led to further improvement of symptoms, as assessed at week ten.

Figure 1a:: A 46-year-old female patient with stump hyperhidrosis: Application of a plastic wrap to recreate the environment that normally leads to stump sweating
Figure 1b:: Iodine-starch test: Result at first presentation
Figure 1c:: Iodine-starch test: Result two weeks after treatment with topical glycopyrrolate

Residual limb hyperhidrosis is thought to be a result of disturbed heat dissipation due to decreased body surface area and changed sympathetic activity in the stump.2 Moreover, younger age, transtibial and traumatic amputation have been found to be predictive factors of more severe sweating.1 Evidence-based guidelines for the management of stump hyperhidrosis are lacking. Except from diverse topical antiperspirants and aluminium chloride preparations, botulinum toxin A and B have been successfully employed on patients with stump hyperhidrosis, while one case report has demonstrated efficacy of microwave ablation on this condition.3,4

Systemic anticholinergic drugs have shown benefit in reducing sweat production in patients with hyperhidrosis, but their adverse event profile limits their use. Topical anticholinergic agents block the activation of acetylcholine receptors in peripheral sweat glands, inhibiting sweat production. Among them, only glycopyrronium tosylate 3.7% cloth has been approved by Food and Drug Administration for the treatment of axillary hyperhidrosis. Further agents include topical oxybutynine in the form of gel (3% and 10%) and skin patch as well as glycopyrronium bromide (also known as glycopyrrolate), available in concentrations of 0.5–4% in the form of cream, gel, solution, spray or pads which have shown promising results in different forms of focal hyperhidrosis.5 However, we were unable to find any previous reports on treatment of stump hyperhidrosis with anticholinergic agents. In the above case, treatment with topical glycopyrrolate could lead to an objective (iodine-starch test) and subjective (hyperhidrosis disease severity scale) improvement of stump hyperhidrosis.

Residual limb hyperhidrosis affects patients with chronic diseases such as type I and II diabetes mellitus and peripheral arterial disease but also young, otherwise healthy, active-duty individuals who undergo traumatic amputations at an exceedingly high rate due to car accidents or on-going military engagements nowadays. These patients sweat with exertion, and because of the water-resistant liner, that is used to anchor the prosthesis to the residual limb, there is no mechanism for sweat evaporation. Large double-blind studies are difficult to design and implement for such special populations. However, we consider that topical glycopyrrolate may represent a cost-effective and easily applicable treatment option, facilitating improvement of prosthetic fit and function and, thereby, quality of life.

Declaration of patient consent

The patient's consent is not required as the patient's identity is not disclosed or compromised.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


  1. , , , . Incidence, severity, and impact of hyperhidrosis in people with lower-limb amputation. J Rehabil Res Dev. 2015;52:31-40.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , . Sympathetic nerve activity to amputated lower leg in humans: Evidence of altered skin vasoconstrictor discharge. Pain. 2002;98:37-45.
    [CrossRef] [Google Scholar]
  3. , , . Botulinum toxin: An effective treatment for prosthesis-related hyperhidrosis in patients with traumatic amputations. Indian Dermatol Online J. 2015;6:1-3.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , . Use of a microwave device for treatment of amputation residual limb hyperhidrosis. Dermatol Surg. 2017;43:149-52.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , . Management strategies of palmar hyperhidrosis: Challenges and solutions. Clin Cosmet Investig Dermatol. 2019;12:733-44.
    [CrossRef] [PubMed] [Google Scholar]

Fulltext Views

PDF downloads
View/Download PDF
Download Citations
Show Sections